Keyword: Karl-Ludwig Kley
News
17.02.2016
- Germany’s Merck KGaA has signed a new framework agreement with Israel’s Weizmann Institute of Science, extending their partnership for another three years with the option for...
Markets & Companies
07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
Markets & Companies
04.09.2015
- Around the globe, market conditions for chemical industry players remained volatile and challenging, corporate chieftains said unanimously in reporting on the second quarter and...
News
01.07.2015
- German chemicals and pharmaceuticals producer Merck KGaA has announced it will take full control of Qlight Nanotech, based at Jerusalem, Israel. A spin-off of Yissum, the...
News
23.03.2015
- Germany's Merck KGaA will promote its deputy chief executive, Stefan Oschmann, to replace current CEO Karl-Ludwig Kley next year, Manager Magazin reported on Friday. Oschmann, 57...
Markets & Companies
13.03.2015
- Both European and US pharmaceutical industry players are highly research-oriented and possess very diversified portfolios. While each country has its national champions, Swiss...
News
23.09.2014
- In the biggest acquisition in the history of the family-owned company, Darmstadt Germany-based chemicals, pharmaceuticals and laboratory products manufacturer Merck KGaA is opening...
News
03.09.2014
- Germany's chemical industry association, Verband der Chemischen Industrie (VCI), has adjusted downward its full-year 2014 business outlook following a weaker than expected second...
